SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-021650
Filing Date
2024-05-28
Accepted
2024-05-28 17:22:20
Documents
65
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 786974
2 ex31-1.htm EX-31.1 14913
3 ex31-2.htm EX-31.2 14535
4 ex32-1.htm EX-32.1 5609
5 ex32-2.htm EX-32.2 5612
  Complete submission text file 0001493152-24-021650.txt   4547923

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE tvgn-20240331.xsd EX-101.SCH 42354
7 XBRL CALCULATION FILE tvgn-20240331_cal.xml EX-101.CAL 52051
8 XBRL DEFINITION FILE tvgn-20240331_def.xml EX-101.DEF 200107
9 XBRL LABEL FILE tvgn-20240331_lab.xml EX-101.LAB 356806
10 XBRL PRESENTATION FILE tvgn-20240331_pre.xml EX-101.PRE 288134
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 542509
Mailing Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059
Business Address 15 INDEPENDENCE BOULEVARD, SUITE 410 WARREN NJ 07059 646-807-8832
Tevogen Bio Holdings Inc. (Filer) CIK: 0001860871 (see all company filings)

IRS No.: 981597194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41002 | Film No.: 24993094
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)